Announcements Trials

Browse Landscape

Phase

Status

Recruiting 6 Completed 3 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 35 Breast Neoplasms 20 Neoplasms 19 Fatigue 9 Prostatic Neoplasms 4 Lung Neoplasms 4 Hematologic Neoplasms 4 Colorectal Neoplasms 4 Obesity 3 Weight Loss 2 Smoking 2 Sedentary Behavior 2 Postoperative Complications 2 Ovarian Neoplasms 2 Mixed Cancer 2 Lymphedema 2 Frailty 2 Colonic Neoplasms 2 Cardiotoxicity 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urologic Neoplasms 1 Urinary Incontinence 1 Stomach Neoplasms 1 Sarcoma 1 Risk Reduction Behavior 1 Rehabilitation After Lung Cancer Surgery 1

Interventions

Carboplatin 84 Cisplatin 79 Pemetrexed 72 Docetaxel 62 Drug Therapy 44 Gemcitabine 43 Erlotinib Hydrochloride 42 Gefitinib 38 Radiotherapy 36 Paclitaxel 36 pembrolizumab 31 Bevacizumab 29 icotinib 28 osimertinib 27 anlotinib 26 Nivolumab 26 camrelizumab 23 Vinorelbine 23 Radiosurgery 20 aumolertinib 18 atezolizumab 17 sintilimab 16 apatinib 16 Endostatins 16 endostar protein 15 durvalumab 14 Surgical Procedures, Operative 13 Immunotherapy 13 Immune Checkpoint Inhibitors 12 Blood Specimen Collection 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma, Non-Small-Cell Lung × Exercise × Clear all

NCT03334071 2019-07-08

EMBRACE

University Hospital Southampton NHS Foundation Trust

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡